Comparative Pharmacology
Head-to-head clinical analysis: NUROMAX versus TRACRIUM PRESERVATIVE FREE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NUROMAX versus TRACRIUM PRESERVATIVE FREE.
NUROMAX vs TRACRIUM PRESERVATIVE FREE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Neuromuscular blocking agent; competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction, preventing depolarization and muscle contraction.
Competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction, blocking depolarization and preventing muscle contraction.
0.1 mg/kg IV bolus, then 0.015 mg/kg IV as needed for neuromuscular blockade.
Initial dose 0.4-0.5 mg/kg IV bolus for intubation; maintenance 0.08-0.1 mg/kg IV every 20-45 minutes as needed or continuous infusion 5-10 mcg/kg/min
None Documented
None Documented
Terminal half-life: 1.5-2.5 hours; prolonged in renal impairment (up to 5 hours) and hepatic disease
Terminal elimination half-life: 20-30 minutes (healthy adults). Clinically, recovery is rapid due to redistribution and Hofmann elimination; prolonged in hypothermia or acidosis.
Renal: 80-90% unchanged; biliary: 10-20%
Renal: 10-20% unchanged; biliary/fecal: 50-60% as metabolites and parent drug; Hofmann elimination (non-enzymatic) accounts for ~45% of clearance.
Category C
Category C
Neuromuscular Blocking Agent
Neuromuscular Blocking Agent